You will be surprised to know that most of the deaths in the world are due to heart attacks. Whatever treatments are available for this, they are either very expensive or out of reach of the people. The situation that the number of heart disease is increasing rapidly. Biotech company Verve Therapeutics has a solution to this problem. They say that to prevent the formation of bad cholesterol, changing the human genome can be a good way.
The company's CEO Shekhar Kathiresan says that it can be a permanent solution to heart diseases. According to a report published in Bloomberg, Verve Therapeutics has received support from Google Ventures. Shekhar Kathiresan says that we are probably going to do this model 'one and done'.